The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C01 | Cardiac therapy | |
| 3 | C01B | Antiarrhythmics, class I and III | |
| 4 | C01BC | Antiarrhythmics, class Ic |
| Code | Title | |
|---|---|---|
| C01BC03 | Propafenone | |
| C01BC04 | Flecainide | |
| C01BC07 | Lorcainide | |
| C01BC08 | Encainide | |
| C01BC09 |
| Active Ingredient | Description | |
|---|---|---|
| Flecainide |
Flecainide acetate is a Class IC antiarrhythmic agent used for the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias. Electrophysiologically, flecainide is a local anaesthetic-type (Class IC) of antiarrhythmic compound. It is an amide type of local anaesthetic, being structurally related to procainamide and encainide in so far as these agents are also benzamide derivatives. |
|
| Propafenone |
Propafenone is a class IC anti-arrhythmic agent. It has a stabilising action on myocardial membranes, reduces the fast inward current carried by sodium ions with a reduction in depolarisation rate and prolongs the impulse conduction time in the atrium, AV node and primarily, in the His-Purkinje system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ARYTHMOL Film coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RYTHMOL SR Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| RYTMONORM Film-coated tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
